
|Articles|September 23, 2022
Optic relief: Bottom Line
Author(s)Jon Carter
Check out this week's cartoon!
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
How Lytenava's FDA approval will impact clinical treatment of nAMD
2
Perceived stress may precede worsening dry eye symptoms in young adults, study finds
3
A primer on oral omega-3s and dry eye disease
4
Duravyu misses primary end point in first pivotal wet AMD trial; secondary durability signals hold
5


















